Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients

Journal of Infection

Volumn 54, Issue 6, 2007, Pages 567-571

  Poutsiaka, Debra D ^a   Skiffington, Serena ^a   Miller, Kenneth B ^a   Hadley, Susan ^a   Snydman, David R ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Daptomycin; Neutropenia; VRE BSI

Indexed keywords

AMPICILLIN; DAPTOMYCIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; EMERGENCY TREATMENT; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HUMAN CELL; LOADING DRUG DOSE; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NEUTROPHIL COUNT; NONHUMAN; OPEN STUDY; OUTCOME ASSESSMENT; SINGLE DRUG DOSE; SURVIVAL TIME;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; DAPTOMYCIN; ENTEROCOCCUS FAECIUM; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; NEUTROPENIA; STEM CELL TRANSPLANTATION; VANCOMYCIN RESISTANCE;

EID: 34248360771     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2006.11.007     Document Type: Article

References (24)

1. DiazGranados C.A., and Jernigan J.A. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. Journal of Infectious Diseases 191 4 (2005) 588-595
2. Koc Y., Snydman D.R., Schenkein D.S., and Miller K.B. Vancomycin-resistant enterococcal infections in bone marrow transplant recipients. Bone Marrow Transplantation 22 2 (1998) 207-209
3. Vergis E.N., Hayden M.K., Chow J.W., Snydman D.R., Zervos M.J., Linden P.K., et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. a prospective multicenter study. Annals of Internal Medicine 135 7 (2001) 484-492
4. Akins R.L., and Rybak M.J. Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrobial Agents & Chemotherapy 45 2 (2001) 454-459
5. Snydman D.R., Jacobus N.V., McDermott L.A., Lonks J.R., and Boyce J.M. Comparative in vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens. Antimicrobial Agents & Chemotherapy 44 12 (2000) 3447-3450
6. Steenbergen J.N., Alder J., Thorne G.M., and Tally F.P. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. Journal of Antimicrobial Chemotherapy 55 3 (2005) 283-288
7. DesJardin J.A., Falagas M.E., Ruthazer R., Griffith J., Wawrose D., Schenkein D., et al. Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer. Annals of Internal Medicine 131 9 (1999) 641-647
8. Kapur D., Dorsky D., Feingold J.M., Bona R.D., Edwards R.L., Aslanzadeh J., et al. Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplantation 25 2 (2000) 147-152
9. Newell K.A., Millis J.M., Arnow P.M., Bruce D.S., Woodle E.S., Cronin D.C., et al. Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation 65 3 (1998) 439-442
10. Song X., Srinivasan A., Plaut D., and Perl T.M. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs. Infection Control & Hospital Epidemiology 24 4 (2003) 251-256
11. Kvirikadze N., Suseno M., Vescio T., Kaminer L., and Singh K. Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia. Scandinavian Journal of Infectious Diseases 38 4 (2006) 290-292
12. Salgado C.D., and Farr B.M. Outcomes associated with vancomycin-resistant enterococci: a meta-analysis. Infection Control & Hospital Epidemiology 24 9 (2003) 690-698
13. Caron F., Kitzis M.D., Gutmann L., Cremieux A.C., Maziere B., Vallois J.M., et al. Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium. Antimicrobial Agents & Chemotherapy 36 12 (1992) 2611-2616
14. Louie A., Baltch A.L., Ritz W.J., Smith R.P., and Asperilla M. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci. Chemotherapy 39 5 (1993) 302-309
15. Rand K.H., and Houck H. Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci. Journal of Antimicrobial Chemotherapy 53 3 (2004) 530-532
16. Pankey G., Ashcraft D., and Patel N. In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin. Antimicrobial Agents & Chemotherapy 49 12 (2005) 5166-5168
17. Cilli F., Aydemir S., and Tunger A. In vitro activity of daptomycin alone and in combination with various antimicrobials against Gram-positive cocci. Journal of Chemotherapy 18 1 (2006) 27-32
18. Smith P.F., Birmingham M.C., Noskin G.A., Meagher A.K., Forrest A., Rayner C.R., et al. Safety, efficacy and pharmacokinetics of linezolid for treatment of resistant Gram-positive infections in cancer patients with neutropenia. Annals of Oncology 14 5 (2003) 795-801
19. Linden P.K., Moellering Jr. R.C., Wood C.A., Rehm S.J., Flaherty J., Bompart F., et al. Treatment of vancomycin-resistant Enterococcus faecium infections with quinupristin/dalfopristin. Clinical Infectious Diseases 33 11 (2001) 1816-1823
20. Sabol K., Patterson J.E., Lewis II J.S., Owens A., Cadena J., and Jorgensen J.H. Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy. Antimicrobial Agents & Chemotherapy 49 4 (2005) 1664-1665
21. Long J.K., Choueiri T.K., Hall G.S., Avery R.K., and Sekeres M.A. Daptomycin-resistant Enterococcus faecium in a patient with acute myeloid leukemia. Mayo Clinic Proceedings 80 9 (2005) 1215-1216
22. Gonzales R.D., Schreckenberger P.C., Graham M.B., Kelkar S., DenBesten K., and Quinn J.P. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 357 9263 (2001) 14
23. Herrero I.A., Issa N.C., and Patel R. Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. New England Journal of Medicine 346 11 (2002) 867-869
24. Rahim S., Pillai S.K., Gold H.S., Venkataraman L., Inglima K., and Press R.A. Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid. Clinical Infectious Diseases 36 11 (2003) 1